182 related articles for article (PubMed ID: 33709497)
1. Redox-sensitive signalling pathways regulated by human papillomavirus in HPV-related cancers.
Cruz-Gregorio A; Aranda-Rivera AK
Rev Med Virol; 2021 Nov; 31(6):e2230. PubMed ID: 33709497
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus-related Cancers and Mitochondria.
Cruz-Gregorio A; Aranda-Rivera AK; Pedraza-Chaverri J
Virus Res; 2020 Sep; 286():198016. PubMed ID: 32445871
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor erythroid 2-related factor 2 in human papillomavirus-related cancers.
Cruz-Gregorio A; Aranda-Rivera AK; Pedraza-Chaverri J
Rev Med Virol; 2022 May; 32(3):e2308. PubMed ID: 34694662
[TBL] [Abstract][Full Text] [Related]
4. Cellular redox, cancer and human papillomavirus.
Cruz-Gregorio A; Manzo-Merino J; Lizano M
Virus Res; 2018 Feb; 246():35-45. PubMed ID: 29337161
[TBL] [Abstract][Full Text] [Related]
5. Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.
Morgan EL; Macdonald A
Viruses; 2020 Sep; 12(9):. PubMed ID: 32899142
[TBL] [Abstract][Full Text] [Related]
6. Lipid metabolism and oxidative stress in HPV-related cancers.
Cruz-Gregorio A; Aranda-Rivera AK; Ortega-Lozano AJ; Pedraza-Chaverri J; Mendoza-Hoffmann F
Free Radic Biol Med; 2021 Aug; 172():226-236. PubMed ID: 34129929
[TBL] [Abstract][Full Text] [Related]
7. Chapter 1: HPV in the etiology of human cancer.
Muñoz N; Castellsagué X; Berrington de González A; Gissmann L
Vaccine; 2006 Aug; 24 Suppl 3():S3/1-10. PubMed ID: 16949995
[TBL] [Abstract][Full Text] [Related]
8. Risk of human papillomavirus-associated cancers among persons with AIDS.
Chaturvedi AK; Madeleine MM; Biggar RJ; Engels EA
J Natl Cancer Inst; 2009 Aug; 101(16):1120-30. PubMed ID: 19648510
[TBL] [Abstract][Full Text] [Related]
9. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
[TBL] [Abstract][Full Text] [Related]
10. Redox-sensitive signaling pathways in renal cell carcinoma.
Cruz-Gregorio A; Aranda-Rivera AK; Pedraza-Chaverri J; Solano JD; Ibarra-Rubio ME
Biofactors; 2022 Mar; 48(2):342-358. PubMed ID: 34590744
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus: often harmless but in some cases carcinogenic.
Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
[TBL] [Abstract][Full Text] [Related]
12. The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy.
Zhang L; Zhao Y; Tu Q; Xue X; Zhu X; Zhao KN
Curr Med Chem; 2021; 28(5):893-909. PubMed ID: 32003657
[TBL] [Abstract][Full Text] [Related]
13. [Human papillomavirus nonavalent vaccine. Update 2017].
Bosch FX; Moreno D; Redondo E; Torné A
Semergen; 2017; 43(4):265-276. PubMed ID: 28549940
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of human papillomavirus vaccination.
Dillner J; Arbyn M; Unger E; Dillner L
Clin Exp Immunol; 2011 Jan; 163(1):17-25. PubMed ID: 21062269
[TBL] [Abstract][Full Text] [Related]
15. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.
Graham SV
Clin Sci (Lond); 2017 Sep; 131(17):2201-2221. PubMed ID: 28798073
[TBL] [Abstract][Full Text] [Related]
16. Redox control of viral carcinogenesis: The human papillomavirus paradigm.
Foppoli C; De Marco F; Cini C; Perluigi M
Biochim Biophys Acta; 2015 Aug; 1850(8):1622-32. PubMed ID: 25534611
[TBL] [Abstract][Full Text] [Related]
17. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
18. Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway.
Hansen BT; Campbell S; Nygård M
BMJ Open; 2018 Feb; 8(2):e019005. PubMed ID: 29476028
[TBL] [Abstract][Full Text] [Related]
19. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
20. Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers.
Dong Z; Hu R; Du Y; Tan L; Li L; Du J; Bai L; Ma Y; Cui H
Front Immunol; 2020; 11():586796. PubMed ID: 33488587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
